Acute pancreatitis is a common condition that affects patients with varying degrees of severity and may lead to significant morbidity and mortality. The present article will review the current paradigm in acute pancreatitis management within the first 72 h of diagnosis.
INTRODUCTION
Acute pancreatitis is a common condition with an annual cost of 2.6 billion dollars in the US [1, 2] . Although the overall population mortality rate for acute pancreatitis has remained unchanged, the incidence appears to be increasing [3, 4] . No pharmacological therapy currently exists to treat acute pancreatitis; however, data from both observational studies and randomized controlled trials have established best practices that lead to reduced morbidity and mortality for patients with this condition. The present article will briefly describe the diagnosis, cause, and prognosis of acute pancreatitis followed by the current paradigms in acute pancreatitis management within the first 72 h of diagnosis -a period during which appropriate risk stratification and management is critical to optimize patient outcomes for this disease. A number of recent guidelines have addressed this topic, including from the American College of Gastroenterology (ACG) [5] , the International Association of Pancreatology (IAP), and the American Pancreatic Association (APA) [6] , and, most recently, the American Gastroenterological Association (AGA) [7 && ]. Relevant recommendations from these expert groups will be summarized later.
MAIN TEXT

Diagnosis
The diagnosis of acute pancreatitis is established by the presence of at least two of the following: stereotypical abdominal pain, serum amylase, and/ or lipase greater than three times the upper limit of normal, and/or characteristic findings on abdominal imaging [8, 9] . Patients with acute pancreatitis typically present with mid-epigastric and/or right upper quadrant pain, that is constant, stabbing in character with radiation to the back or flank. Contrast-enhanced computed tomography (CT) and/or MRI of the pancreas should be reserved for patients in whom the diagnosis is uncertain from clinical and laboratory evaluation alone or patients who fail to improve clinically within the first 72 h of hospitalization [10, 11] . Fig. 1 demonstrates CT imaging of a patient presenting with acute biliary pancreatitis.
Causes
Gallstones and alcohol are by far the most common causes of acute pancreatitis and thus transabdominal ultrasound and alcohol use history should be obtained in all patients presenting with the condition [12, 13] . Alcohol-induced acute pancreatitis is generally considered to require more than 50 g of alcohol per day, although less than 5% of chronic alcoholics develop acute pancreatitis for reasons that are uncertain [14] [15] [16] . In the absence of gallstones or a significant history of alcohol use, a serum triglyceride level should be obtained and considered the cause if more than 1000 mg/dl [17, 18] . In medication induced pancreatitis, the most wellestablished agents are 6-mercaptopurine or azathioprine, isoniazid, loop diuretics, and didanosine [19] . Although rare, a pancreatic tumor or cystic neoplasm should be considered as a cause of acute pancreatitis in patients older than age 40 without another obvious cause [20, 21] . Post-ERCP pancreatitis is the most common serious adverse event attributed to the procedure, although there is debate over how to define this entity [22, 23] . Most studies use the consensus definition, which requires the presence of new or worsened abdominal pain, amylase at least three times normal at more than 24 h after the procedure, and requiring admission or prolongation of planned admission to 2-3 days [24,25 & ]. Idiopathic acute pancreatitis is defined as pancreatitis with no cause established after initial laboratory tests, transabdominal ultrasound, and CT and should be referred to a center of expertise for further evaluation [5, 26] .
Prognosis
Initial evaluation of a patient with acute pancreatitis should include assessment of systemic inflammatory response criteria and resuscitative measures should be initiated if needed. Numerous acute pancreatitis severity scoring systems exist to assist in predicting a patient's clinical course, however many are cumbersome to calculate and often take more than 72 h to become positive, at which point the patient's clinical course is likely obvious. These scores, including APACHE II, Ranson and Glasgow demonstrate relatively poor positive predictive
KEY POINTS
Acute pancreatitis is defined by two of the following: stereotypical abdominal pain, amylase and/or lipase more than three times the upper limit of normal and imaging findings consistent with the condition.
Patients presenting with acute pancreatitis should undergo transabdominal ultrasound to evaluate for gallstone disease and a thorough alcohol use history should be obtained.
Fluid resuscitation in acute pancreatitis should focus on improving heart rate, mean arterial pressure, central venous pressure, urine output, blood urea nitrogen concentration, and hematocrit. Ringer's lactate is generally favored over physiological saline as the resuscitative fluid of choice.
Early oral feeding should be encouraged in acute pancreatitis and if a patient cannot tolerate oral intake, placement of an enteral feeding tube should be considered.
Cholecystectomy during the same admission of biliary pancreatitis should be pursued and patient with acute pancreatitis secondary to alcohol should receive counseling on alcohol abuse. value [27] . Even new scoring systems, including the Bedside Index of Severity in Acute Pancreatitis, have not been shown to be more accurate than the previous scoring systems [28, 29] .
In general, the current practice in determining acute pancreatitis severity is based upon the revised Atlanta criteria (Table 1 ) [9] . Mild acute pancreatitis is defined by absence of organ failure or local complications; moderately severe acute pancreatitis is defined by transient organ failure (less than 48 h) and/or local complications; severe acute pancreatitis is defined by persistent organ failure (greater than 48 h). Organ failure is typically defined using the Modified Marshall scoring system for organ dysfunction (Table 2 ) [30] . Patients with severe acute pancreatitis should be admitted to an intensive care unit or intermediary care setting whenever possible [5] . Factors associated with worse outcomes in acute pancreatitis include advanced age, multiple comorbid health problems, elevated body mass index, presence of systemic inflammatory response syndrome, elevated BUN and/or hematocrit, pleural effusions, and/or infiltrates and altered mental status [31] [32] [33] [34] .
Management: fluid resuscitation
Fluid therapy to prevent hypovolemia and organ hypoperfusion is a well established cornerstone of sepsis care, which has numerous physiological similarities to acute pancreatitis [35] . Typical goaldirected therapy focuses on heart rate, mean arterial pressure, central venous pressure, urine output, blood urea nitrogen concentration, and hematocrit. These goals are outlined in Table 3 . Recent AGA, ACG, and IAP/APA guidelines recommend goaldirected therapy for fluid resuscitation of patients with acute pancreatitis utilizing various parameters [5,6,7 && ]. However, it should be acknowledged that the evidence supporting these recommendations is relatively weak, and compared with nontargeted therapy, there is not clear evidence that goaldirected therapy results in significant improvement in important outcomes, such as mortality, prevention of pancreatic necrosis, or decrease in the rate of persistent multiple organ failure [7 && ]. Nevertheless, using physiologic metrics to guide initial fluid resuscitation is important both to ensure adequate organ perfusion and to avoid overly aggressive fluid therapy, which can be associated with harms in acute pancreatitis, including respiratory complications and abdominal compartment syndrome [36, 37] . It should be noted that aggressive fluid resuscitation is most useful in the first 12-24 h of admission, and should generally be curtailed after this point to ovoid fluid overload [5, 38, 39] .
Two randomized controlled trials evaluating Ringer's lactate versus physiological saline as the optimal fluid solution for resuscitation demonstrated a reduction in systemic inflammation [40,41 & ]. These studies may have limited application, however, as they used surrogate markers of [5, 6] . The recommended infusion rate is 250-500 ml/h, unless there are cardiovascular, renal, or other related comorbid conditions present [5] . Hydroxyethyl starch (HES) has also been used as a resuscitative fluid in acute pancreatitis [42 && ]. However, the studies to date failed to demonstrate improved mortality compared with fluid resuscitation without HES and in one trial multiple organ failure was significantly increased in patients receiving HES fluids [43, 44] . For these reasons, HES-containing fluid is not recommended as a resuscitative agent in acute pancreatitis.
Management: prophylactic antibiotics
Mortality doubles when pancreatic or peripancreatic necrosis becomes infected in patients with organ failure [45 & ]. Previous rationale for administering prophylactic antibiotics was in hopes of reducing the risk for infected necrosis and thereby improving morbidity and mortality. In patients with predicted severe acute pancreatitis and necrotizing pancreatitis, older trial data suggest that prophylactic antibiotics were associated with a reduction in the risk of infected pancreatic and peripancreatic necrosis. However, more recent trial data (since 2002) demonstrate no differences in risks of infected pancreatic and peripancreatic necrosis or mortality [46] . In patients with mild acute pancreatitis, there appears to be no role for prophylactic antibiotics in the absence of cholangitis or other extrapancreatic infections. Further, prophylactic antibiotics have not shown an impact on the rates of persistent single or multiple organ failure, or hospital length of stay [47] . Accordingly, recent ACG and AGA guidelines have recommended against the routine use of prophylactic antibiotics in patients with acute pancreatitis [5, 7 && ].
Management: enteral feeding
Historical management of acute pancreatitis allowed the patient to take little by mouth in order to avoid a theoretical risk of further stimulating an inflamed pancreas. This paradigm has shifted dramatically over the last decade as further evidence has accrued to suggest early feeding does not exacerbate pancreatic parenchymal inflammation, and is actually beneficial in acute pancreatitis. This rationale stems from the understanding that enteral nutrition likely serves to protect the mucosal barrier of the gut and reduce bacterial translocation. This in turn may reduce the risk of developing infected pancreatic and peripancreatic necrosis [48] . Delayed feeding (generally defined as >24 h) is associated with higher rates of infected peripancreatic necrosis, multiple organ failure, and total necrotizing pancreatitis [49] [50] [51] . Success of early feeding has been demonstrated with low-fat, normal fat, and soft or solid consistency and thus it is not necessary to start patients with acute pancreatitis on a clear liquid diet before advancement to a solid diet [52, 53] . Patients who cannot tolerate an oral diet may require enteral tube placement for nutritional support; however, the risk of aspiration should be considered in patients with severe acute pancreatitis. There does not appear to be an advantage to post-pyloric tube placement over gastric tube placement [54] . There is, however, clear evidence demonstrating enteral nutrition over total parenteral nutrition (TPN) is associated with reduced risk of infected peripancreatic necrosis and multiple organ failure [55, 56] . For this reason, TPN use in acute pancreatitis is discouraged.
Management: urgent ERCP
Urgent ERCP (typically defined as occurring within the first 72 h) is indicated in patients with acute cholangitis regardless of the presence of acute biliary (i.e. gallstone) pancreatitis [57, 58] . However, in patients with gallstone pancreatitis who do not have cholangitis, the role of ERCP has been debated. Data from randomized controlled trials on this topic show that compared to conservative management, urgent ERCP in gallstone pancreatitis has not been demonstrated to improve critical outcomes, such as mortality and multiple organ failure, infected pancreatic and peripancreatic necrosis, or total rates of necrotizing pancreatitis [59] [60] [61] [62] . Thus, urgent ERCP is typically not recommended in acute pancreatitis in the absence of acute cholangitis. There may be a reduction in hospital length of stay for patients with acute pancreatitis undergoing ERCP, although this was only demonstrated in a single study [63] .
Management: cholecystectomy
In cases of acute pancreatitis secondary to gallstone disease, cholecystectomy should be performed to prevent recurrent episodes of acute pancreatitis [64] . The optimal timing of surgery weighs the challenges of operating on a patient with an acutely inflamed pancreas against the risk for recurrent gallstone-related complications. Patients discharged without a cholecystectomy have a significant risk of Management of acute pancreatitis James and Crockett recurrent acute pancreatitis and/or cholangitis [65] . Data from a randomized controlled clinical trial found that cholecystectomy during the initial admission for patients with gallstone pancreatitis was associated with reduction in mortality and gallstone-related complications, readmission for recurrent pancreatitis, and pancreaticobiliary complications [66 & ]. Therefore, current recommendations favor cholecystectomy during the same admission when the etiology of acute pancreatitis is determined to be gallstones [42 && ].
Management: alcohol counseling
In patients with a first attack of acute pancreatitis with a clear history of alcohol use, counseling has demonstrated a reduction in total hospital admission rates and can reduce the risk of acute pancreatitis recurrence [67, 68] . The screening, brief intervention, and referral to treatment approach to alcohol counseling is effective in reducing alcohol consumption [69] . Therefore, because reduction or cessation of alcohol abuse clearly reduces the risk of recurrent alcoholic acute pancreatitis [70] , and given the negligible harms and relatively low cost of the intervention, it is generally recommended that patients presenting with acute pancreatitis secondary to alcohol abuse receive at least brief alcohol counseling during the index admission.
CONCLUSION
Current evidence supports the benefit of goaldirected fluid resuscitation and early oral feeding in all patients with acute pancreatitis. Patients with biliary pancreatitis should preferentially undergo same-admission cholecystectomy. Alcohol counseling for patients with alcohol-induced pancreatitis should be provided. Current data do not support the routine use of prophylactic antibiotics in acute pancreatitis or routine ERCP in patients with acute pancreatitis without accompanying cholangitis.
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